ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	9/111	120/7206	8.85824233611e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/111	191/7206	0.000159611593407
ko04621	NOD-like receptor signaling pathway	9/111	157/7206	0.000667271604668
ko04215	Apoptosis - multiple species	5/111	47/7206	0.000725970331606
ko04380	Osteoclast differentiation	8/111	134/7206	0.00102649844295
ko05164	Influenza A	9/111	167/7206	0.00103837283174
ko05131	Shigellosis	6/111	82/7206	0.00157987794609
ko04670	Leukocyte transendothelial migration	8/111	151/7206	0.00220431571159
ko04060	Cytokine-cytokine receptor interaction	9/111	191/7206	0.00263244054975
ko04660	T cell receptor signaling pathway	7/111	124/7206	0.00291736517985
ko04725	Cholinergic synapse	8/111	160/7206	0.00315927843076
ko04062	Chemokine signaling pathway	9/111	201/7206	0.00370401730306
ko05100	Bacterial invasion of epithelial cells	6/111	99/7206	0.00409539020771
ko04932	Non-alcoholic fatty liver disease (NAFLD)	8/111	182/7206	0.00685266507291
ko04966	Collecting duct acid secretion	3/111	26/7206	0.00714627474985
ko05160	Hepatitis C	7/111	153/7206	0.00913298071925
ko04722	Neurotrophin signaling pathway	7/111	160/7206	0.0115175190478
ko04211	Longevity regulating pathway	6/111	123/7206	0.0115519298705
ko05323	Rheumatoid arthritis	5/111	89/7206	0.0118021061126
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/111	92/7206	0.0134866728344
ko05166	HTLV-I infection	10/111	292/7206	0.0142268454581
ko04064	NF-kappa B signaling pathway	5/111	96/7206	0.0159756956252
ko04650	Natural killer cell mediated cytotoxicity	5/111	97/7206	0.0166427381603
ko05161	Hepatitis B	7/111	173/7206	0.0170970928409
ko04933	AGE-RAGE signaling pathway in diabetic complications	6/111	135/7206	0.0176232979961
ko04620	Toll-like receptor signaling pathway	5/111	100/7206	0.0187545280073
ko04931	Insulin resistance	6/111	137/7206	0.0188142694709
ko04217	Necroptosis	7/111	178/7206	0.0196816291289
ko04210	Apoptosis	7/111	180/7206	0.0207883962967
ko04080	Neuroactive ligand-receptor interaction	1/111	423/7206	0.0220264729845
ko00051	Fructose and mannose metabolism	3/111	42/7206	0.026430795376
ko05215	Prostate cancer	5/111	111/7206	0.0279853894771
ko01524	Platinum drug resistance	4/111	76/7206	0.0293186371258
ko04721	Synaptic vesicle cycle	4/111	80/7206	0.0345087474115
ko05230	Central carbon metabolism in cancer	4/111	81/7206	0.0358846119219
ko00120	Primary bile acid biosynthesis	2/111	20/7206	0.0372984842054
ko05162	Measles	5/111	120/7206	0.0373762359768
ko04152	AMPK signaling pathway	6/111	161/7206	0.0375934859662
ko04145	Phagosome	6/111	162/7206	0.0385672779775
ko05212	Pancreatic cancer	4/111	83/7206	0.0387307655825
ko05203	Viral carcinogenesis	9/111	277/7206	0.0390815529466
ko04666	Fc gamma R-mediated phagocytosis	5/111	122/7206	0.0396967166643
ko05220	Chronic myeloid leukemia	4/111	85/7206	0.0417030344808
ko04213	Longevity regulating pathway - multiple species	4/111	86/7206	0.0432364980761
ko04068	FoxO signaling pathway	6/111	167/7206	0.0436780198117
ko05145	Toxoplasmosis	5/111	126/7206	0.0445970696383
ko04662	B cell receptor signaling pathway	4/111	88/7206	0.0463980528485
ko05222	Small cell lung cancer	4/111	89/7206	0.0480260974008
ko05142	Chagas disease (American trypanosomiasis)	5/111	130/7206	0.0498459211667